Skip to main content
. 2018;19(2):387–393. doi: 10.22034/APJCP.2018.19.2.387

Figure 2.

Figure 2

Effect of Treatment with Doxorubicin or Ellagic Acid on Serum AFP (A) and GPC-3 (B) Levels in HCC Rat Model. (a) Significant change at P>0.05 in comparison with the negative control group, (b) Significant change at P>0.05 in comparison with the HCC untreated group.

HHS Vulnerability Disclosure